Price to Earnings (P/E)
since 2005
Paying user area
Try for free
UnitedHealth Group Inc. pages available for free this week:
- Balance Sheet: Assets
- Common-Size Income Statement
- Analysis of Long-term (Investment) Activity Ratios
- Enterprise Value (EV)
- Capital Asset Pricing Model (CAPM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Operating Profit Margin since 2005
- Price to Sales (P/S) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to UnitedHealth Group Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
UnitedHealth Group Inc., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net earnings attributable to UnitedHealth Group common shareholders1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2025 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 15, 2022 | = | ÷ | = | ÷ | |||||||
| Mar 1, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 14, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 12, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 13, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 8, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 9, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 10, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 12, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 7, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 9, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 10, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 10, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 11, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2008 | = | ÷ | = | ÷ | |||||||
| Mar 6, 2007 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of UnitedHealth Group Inc. Annual Report.
The price-to-earnings (P/E) ratio for the observed period demonstrates considerable fluctuation, though generally trending upwards over the long term. Initial values in the early to mid-2000s were relatively high, followed by a period of decline coinciding with economic downturns, and then a subsequent rise. The P/E ratio exhibits sensitivity to both share price and earnings per share (EPS) movements.
- Early Period (2006-2009)
- From 2006 to 2009, the P/E ratio experienced a notable decrease, falling from 24.20 to 11.66. This decline was primarily driven by a significant drop in share price, particularly in 2008 and 2009, while EPS also experienced a decrease during this timeframe. This suggests increased investor uncertainty and potentially a negative market sentiment towards the company during the financial crisis.
- Recovery and Stabilization (2010-2014)
- Between 2010 and 2014, the P/E ratio demonstrated a period of relative stabilization, fluctuating between approximately 9.91 and 18.50. Share price and EPS both generally increased during this period, contributing to the stabilization. The P/E ratio’s movement remained relatively contained, indicating a more predictable valuation.
- Growth Phase (2015-2021)
- From 2015 to 2021, the P/E ratio generally increased, reaching a peak of 26.03 in 2021. This increase was fueled by consistent growth in both share price and EPS. The ratio’s upward trajectory suggests increasing investor confidence and a willingness to pay a higher premium for each dollar of earnings. The period from 2015-2021 shows a strong correlation between EPS growth and P/E expansion.
- Recent Volatility (2022-2026)
- The most recent period, from 2022 to the projected 2026, shows increased volatility in the P/E ratio. The ratio decreased from 22.46 in 2022 to 29.75 in 2024, before declining to 22.20 in 2025 and a projected 22.20 in 2026. This fluctuation is attributable to a combination of share price declines and a decrease in EPS in 2024 and 2025. The projected value for 2026 suggests a potential stabilization, but further monitoring is warranted.
Overall, the P/E ratio demonstrates a cyclical pattern, influenced by broader economic conditions and company-specific performance. While long-term trends indicate growth, recent years have shown increased volatility, requiring careful consideration when assessing the company’s valuation.
Comparison to Competitors
UnitedHealth Group Inc., P/E, long-term trends, comparison to competitors
| UnitedHealth Group Inc. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | |
|---|---|---|---|---|---|
| Mar 2, 2026 | |||||
| Feb 27, 2025 | |||||
| Feb 28, 2024 | |||||
| Feb 24, 2023 | |||||
| Feb 15, 2022 | |||||
| Mar 1, 2021 | |||||
| Feb 14, 2020 | |||||
| Feb 12, 2019 | |||||
| Feb 13, 2018 | |||||
| Feb 8, 2017 | |||||
| Feb 9, 2016 | |||||
| Feb 10, 2015 | |||||
| Feb 12, 2014 | |||||
| Feb 7, 2013 | |||||
| Feb 9, 2012 | |||||
| Feb 10, 2011 | |||||
| Feb 10, 2010 | |||||
| Feb 11, 2009 | |||||
| Feb 21, 2008 | |||||
| Mar 6, 2007 | |||||
| Feb 24, 2006 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
UnitedHealth Group Inc., P/E, long-term trends, comparison to sector (health care equipment & services)
| UnitedHealth Group Inc. | Health Care Equipment & Services | |
|---|---|---|
| Mar 2, 2026 | ||
| Feb 27, 2025 | ||
| Feb 28, 2024 | ||
| Feb 24, 2023 | ||
| Feb 15, 2022 | ||
| Mar 1, 2021 | ||
| Feb 14, 2020 | ||
| Feb 12, 2019 | ||
| Feb 13, 2018 | ||
| Feb 8, 2017 | ||
| Feb 9, 2016 | ||
| Feb 10, 2015 | ||
| Feb 12, 2014 | ||
| Feb 7, 2013 | ||
| Feb 9, 2012 | ||
| Feb 10, 2011 | ||
| Feb 10, 2010 | ||
| Feb 11, 2009 | ||
| Feb 21, 2008 | ||
| Mar 6, 2007 | ||
| Feb 24, 2006 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
UnitedHealth Group Inc., P/E, long-term trends, comparison to industry (health care)
| UnitedHealth Group Inc. | Health Care | |
|---|---|---|
| Mar 2, 2026 | ||
| Feb 27, 2025 | ||
| Feb 28, 2024 | ||
| Feb 24, 2023 | ||
| Feb 15, 2022 | ||
| Mar 1, 2021 | ||
| Feb 14, 2020 | ||
| Feb 12, 2019 | ||
| Feb 13, 2018 | ||
| Feb 8, 2017 | ||
| Feb 9, 2016 | ||
| Feb 10, 2015 | ||
| Feb 12, 2014 | ||
| Feb 7, 2013 | ||
| Feb 9, 2012 | ||
| Feb 10, 2011 | ||
| Feb 10, 2010 | ||
| Feb 11, 2009 | ||
| Feb 21, 2008 | ||
| Mar 6, 2007 | ||
| Feb 24, 2006 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).